Read This Before Considering ChemoMetec A/S (CPH:CHEMM) For Its Upcoming ø13.00 DividendHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets open in 9 hrs 26 minsS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Read This Before Considering ChemoMetec A/S (CPH:CHEMM) For Its Upcoming ø13.00 DividendSimply Wall StSimply Wall St.January 10, 2020ReblogShareTweetShareView photosChemoMetec A/S (CPH:CHEMM) is about to trade ex-dividend in the next 3 days. You can purchase shares before the 14th of January in order to receive the dividend, which the company will pay on the 16th of January.The upcoming dividend for ChemoMetec will put a total of ø13.00 per share in shareholders' pockets, up from last year's total dividends of ø3.00. If you buy this business for its dividend, you should have an idea of whether ChemoMetec's dividend is reliable and sustainable. That's why we should always check whether the dividend payments appear sustainable, and if the company is growing. View our latest analysis for ChemoMetec Dividends are typically paid from company earnings. If a company pays more in dividends than it earned in profit, then the dividend could be unsustainable. ChemoMetec distributed an unsustainably high 112% of its profit as dividends to shareholders last year. Without extenuating circumstances, we'd consider the dividend at risk of a cut.Click here to see how much of its profit ChemoMetec paid out over the last 12 months.CPSE:CHEMM Historical Dividend Yield, January 10th 2020MoreHave Earnings And Dividends Been Growing?Businesses with strong growth prospects usually make the best dividend payers, because it's easier to grow dividends when earnings per share are improving. Investors love dividends, so if earnings fall and the dividend is reduced, expect a stock to be sold off heavily at the same time. That's why it's comforting to see ChemoMetec's earnings have been skyrocketing, up 110% per annum for the past five years.This is ChemoMetec's first year of paying a dividend, which is exciting for shareholders - but it does mean there's no dividend history to examine.Final TakeawayShould investors buy ChemoMetec for the upcoming dividend? It's been growing earnings per share at a pleasant rate, although its dividend payout was not well covered by earnings. ChemoMetec ticks a lot of boxes for us from a dividend perspective, and we think these characteristics should mark the company as deserving of further attention.Want to learn more about ChemoMetec? Here's a visualisation of its historical rate of revenue and earnings growth.We wouldn't recommend just buying the first dividend stock you see, though. Here's a list of interesting dividend stocks with a greater than 2% yield and an upcoming dividend.If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextSome ISS (CPH:ISS) Shareholders Have Copped A Big 57% Share Price DropSimply Wall St.SalMar ASA Annual Results: Here's What Analysts Are Forecasting For Next YearSimply Wall St.bioMérieux S.A. Full-Year Results: Here's What Analysts Are Forecasting For Next YearSimply Wall St.Are Dividend Investors Getting More Than They Bargained For With Euroz Limited's (ASX:EZL) Dividend?Simply Wall St.Why BE Group AB (publ) (STO:BEGR) Is A Dividend RockstarSimply Wall St.Biocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoWhy We’re Not Keen On YHI International Limited’s (SGX:BPF) 3.8% Return On CapitalSimply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance Video